NEOG Neogen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEOG

Price (delayed)

$95.50

Market cap

$5.11B

P/E Ratio

82.33

Dividend/share

N/A

EPS

$1.16

Enterprise value

$5.04B

Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neogen.com/

Highlights

Neogen's equity has increased by 13% YoY and by 3.9% QoQ
The gross profit is up by 7% YoY and by 4.2% from the previous quarter
NEOG's price to earnings (P/E) is 38% more than its 5-year quarterly average of 59.2 and 23% more than its last 4 quarters average of 66.3
The quick ratio is down by 9% since the previous quarter and by 8% year-on-year

Key stats

What are the main financial stats of NEOG
Market
Shares outstanding
53.51M
Market cap
$5.11B
Enterprise value
$5.04B
Valuations
Price to earnings (P/E)
82.33
Price to book (P/B)
6.3
Price to sales (P/S)
11.33
EV/EBIT
66.01
EV/EBITDA
52.33
EV/Sales
11.19
Earnings
Revenue
$450.11M
EBIT
$76.3M
EBITDA
$96.26M
Free cash flow
$57.63M
Per share
EPS
$1.16
Free cash flow per share
$1.08
Book value per share
$15.17
Revenue per share
$8.43
TBVPS
$12.25
Balance sheet
Total assets
$880.22M
Total liabilities
$72.53M
Debt
$0
Equity
$807.68M
Working capital
$509.36M
Liquidity
Debt to equity
0
Current ratio
12.09
Quick ratio
9.59
Net debt/EBITDA
-0.76
Margins
EBITDA margin
21.4%
Gross margin
46.5%
Net margin
13.7%
Operating margin
16.4%
Efficiency
Return on assets
7.4%
Return on equity
8%
Return on invested capital
14.7%
Return on capital employed
9.1%
Return on sales
17%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NEOG stock price

How has the Neogen stock price performed over time
Intraday
0.74%
1 week
4.65%
1 month
15.73%
1 year
44.54%
YTD
20.43%
QTD
7.44%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$450.11M
Gross profit
$209.09M
Operating income
$73.86M
Net income
$61.47M
Gross margin
46.5%
Net margin
13.7%
The company's operating income rose by 11% YoY and by 3.8% QoQ
The gross profit is up by 7% YoY and by 4.2% from the previous quarter
The revenue has grown by 7% YoY and by 3.9% from the previous quarter
The operating margin is up by 3.8% year-on-year

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
P/E
82.33
P/B
6.3
P/S
11.33
EV/EBIT
66.01
EV/EBITDA
52.33
EV/Sales
11.19
NEOG's price to earnings (P/E) is 38% more than its 5-year quarterly average of 59.2 and 23% more than its last 4 quarters average of 66.3
The EPS is up by 3.6% year-on-year
The P/B is 18% more than the last 4 quarters average of 5.3 and 14% more than the 5-year quarterly average of 5.5
Neogen's equity has increased by 13% YoY and by 3.9% QoQ
The price to sales (P/S) is 37% higher than the 5-year quarterly average of 8.2 and 21% higher than the last 4 quarters average of 9.3
The revenue has grown by 7% YoY and by 3.9% from the previous quarter

Efficiency

How efficient is Neogen business performance
The ROA is down by 8% year-on-year
Neogen's return on equity has decreased by 8% YoY
The return on invested capital has declined by 2.6% year-on-year

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total liabilities is up by 18% year-on-year and by 6% since the previous quarter
The total assets has grown by 14% YoY and by 4.1% from the previous quarter
The debt is 100% smaller than the equity
Neogen's equity has increased by 13% YoY and by 3.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.